Labrador Retrievers, a beloved breed in the United States, may inherit an inherited disorder known as skeletal dwarfism (SD2). This genetic condition results in disproportionate dwarfism, where the dog’s legs—especially the front ones—are notably shorter than typical, while the body size remains within normal range. Recognizing the nature of SD2, its genetic transmission, and available testing options enable American breeders to make ethical choices that curb the condition’s prevalence.
SD2 is caused by a recessive mutation in the COL11A2 gene and is classified as a mild form of skeletal dysplasia. Dogs carrying two copies of this mutated gene (homozygous) exhibit shortening and slight bowing of the front limbs. Unlike some other genetic disorders, SD2 usually does not lead to additional health complications or a shortened lifespan.
Adult males affected tend to stand shorter than 55 cm (21.6 inches) at the shoulder, and females are typically under 50 cm (19.7 inches), though these measurements can vary among taller working or field-line Labradors common in the US. Puppies generally appear normal at birth, with discernible limb shortening becoming apparent by approximately six months as their long bones fail to develop properly.
In American Labradors, SD2 follows an autosomal recessive inheritance pattern. This means a dog must receive one copy of the mutant gene from each parent to develop skeletal dwarfism. Dogs fall into three genetic categories:
A mating between two carriers bears a 25% risk of producing affected puppies. Therefore, responsible breeders aim to prevent pairing carriers together, reducing the risk of SD2 becoming more widespread.
Genetic testing is a crucial tool that identifies if a Labrador is clear, a carrier, or affected by SD2, enabling more informed and ethical breeding decisions. This testing helps breeders avoid producing pups with skeletal dwarfism, ultimately benefiting the health and welfare of future generations.
To determine your dog's SD2 status, schedule an appointment with a veterinarian who can collect a DNA sample. Samples commonly accepted include cheek swabs, blood, semen, or tissue. You can then send the sample to accredited veterinary genetic laboratories in the US such as Animal Genetics or Embark Vet, both widely recognized for thorough and reliable canine genetic testing.
These labs usually process results within 10 to 12 business days and will provide clear information stating whether your dog is clear, a carrier, or affected by the SD2 mutation.
American breeders are encouraged to:
Following these best practices safeguards the breed's overall health while honoring established breeding standards and animal welfare.
Skeletal Dwarfism (SD2) in the Labrador Retriever results from a recessive mutation in the COL11A2 gene, causing shortened legs but typically no diminished quality of life. The condition is more often observed in American working or field lines and is inherited through an autosomal recessive pattern.
Genetic testing is widely accessible through US-based veterinary labs and is vital for responsible breeding to prevent affected litters. If you own or plan to breed a Labrador in the US, consider testing to know your dog's genetic status. Avoiding carrier-to-carrier breeding will help reduce the incidence of SD2, contributing to healthier, happier dogs while supporting ethical breeding aligned with American veterinary health standards and the broader goals of breed health preservation.